An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (2)
  • Publications (202)
  • Training (0)
  • User case (2)
  • User meeting (1)
  • Webinar (12)
  • White paper (2)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • (-) Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • (-) Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)
  • Reset filters
  • (-) Gastro-intestinal
  • (-) Pediatric

Impact of lymphopenia on the clinical outcomes of esophageal cancer patients

28/10/2021
/ Publications
/
Chemotherapy

A study by the Tsukuba group, Japan. This study retrospectively reviewed 69 patients with esophageal cancer treated with XRT (n=15) and PBT (n= 54) and...

Assessing concordance between patient-reported and investigator-reported CTCAE after PBT for prostate cancer.

28/09/2021
/ Publications

A study by the Mayo Clinic group. This study examined the acute CTCAE reported by 55 patients (PRO-CTCAE) with high-risk or unfavorable intermediate-risk...

Show&Tell #4: Gastrointestinal cancers

18/11/2021
/ User Meeting
  • Watch this Show & Tell on Gastrointestinal cancers.
  •  
  • Dr Andrew J. Wroe, Director of Proton Physics, and Dr Adeel Kaiser, Radiation Oncologist, will share c...

Technical insights on the treatment of GI cancers.

16/12/2021
/ Publications

Adeel Kaiser, MD from the Department of Radiation Oncology at the Miami Cancer Institute gives some technical insights on the treatment of GI cancers.

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.

11/11/2019
/ Publications

Published in the Red Journal, this study identified patients who benefit most from PBT in terms of predicted 30-year absolute mortality risks (AMR30) from...

Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.

10/10/2021
/ Publications
/
Dosimetry
Reirradiation
Motion Management

 In this guideline document, the dosimetric data and clinical evidence of PBT for esophageal cancer (EC) was summarized and evaluated. The clinical outcome data...

IBA Proton Therapy Conference at ASTRO 2019

15/09/2019
/ Event
/
Immunotherapy
ARC therapy

AMIT MAITY, MD, PhD Executive Vice-Chair Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia "Proton FLASH Radiation...

Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma

30/05/2016
/ Publications
/
Clinical Trial

A randomized trial comparing proton therapy with transarterial chemoembolization (TACE) for hepatocellular carcinoma, reported a trend toward improved local...

Factors associated with LT survival in gemcitabine-concurrent PT for non-metastatic LAPC

07/02/2022
/ Publications

123 patients with locally advanced pancreatic cancer (LAPC) treated with gemcitabine-concurrent proton radiotherapy (GPT) were reviewed in this study by the...

Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review

30/08/2016
/ Publications
/
Toxicity

A systematic review examined clinical outcomes and toxicities of proton therapy for gastrointestinal neoplasms. The findings include that proton therapy was...

Pagination

  • Previous page ‹
    • Page 18
    • Current page 19
    • Page 20
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies